{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:20:41Z","timestamp":1793892041998,"version":"4.8.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SmokeWorks Boston"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Providing sterile drug smoking materials to people who use drugs can prevent the acquisition of infectious diseases and reduce overdose risk. However, there is a lack of understanding of how these practices are being implemented and received by people who use drugs globally.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic review of safer smoking practices was conducted by searching PubMed, PsycInfo, Embase for relevant peer-reviewed, English-language publications from inception or the availability of online manuscripts through December 2022.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 32 peer-reviewed papers from six countries were included. 30 studies exclusively included people who use drugs as participants (<jats:italic>n<\/jats:italic>\u2009=\u200911 people who use drugs; generally, <jats:italic>n<\/jats:italic>\u2009=\u200917 people who smoke drugs, <jats:italic>n<\/jats:italic>\u2009=\u20092 people who inject drugs). One study included program staff serving people who use drugs, and one study included staff and people who use drugs. Sharing smoking equipment (e.g., pipes) was reported in 25 studies. People who use drugs in several studies reported that pipe sharing occurred for multiple reasons, including wanting to accumulate crack resin and protect themselves from social harms, such as police harassment. Across studies, smoking drugs, as opposed to injecting drugs, were described as a crucial method to reduce the risk of overdose, disease acquisition, and societal harms such as police violence. Ten studies found that when people who use drugs were provided with safer smoking materials, they engaged in fewer risky drug use behaviors (e.g., pipe sharing, using broken pipes) and showed improved health outcomes. However, participants across 11 studies reported barriers to accessing safer smoking services. Solutions to overcoming safer smoking access barriers were described in 17 studies and included utilizing peer workers and providing safer smoking materials to those who asked.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This global review found that safer smoking practices are essential forms of harm reduction. International policies must be amended to help increase access to these essential tools. Additional research is also needed to evaluate the efficacy of and access to safer smoking services, particularly in the U.S. and other similar countries, where such practices are being implemented but have not been empirically studied in the literature.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-023-00875-x","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T20:31:59Z","timestamp":1698438719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The utilization and delivery of safer smoking practices and services: a narrative synthesis of the literature"],"prefix":"10.1186","volume":"20","author":[{"given":"Abigail","family":"Tapper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ahern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Graveline-Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam G.","family":"Newberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn M. W.","family":"Hughto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"875_CR1","unstructured":"National Harm Reduction Coalition. Principles of Harm Reduction [Available from: https:\/\/harmreduction.org\/about-us\/principles-of-harm-reduction\/."},{"issue":"3","key":"875_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/09595239500185371","volume":"14","author":"E Single","year":"1995","unstructured":"Single E. Defining harm reduction. Drug Alcohol Rev. 1995;14(3):287\u201390.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"875_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.11.014","volume":"89","author":"R Scheinmann","year":"2007","unstructured":"Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, Flom PL, et al. Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend. 2007;89(1):1\u201312.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"875_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MEG.0b013e3282f16a8c","volume":"20","author":"B Fischer","year":"2008","unstructured":"Fischer B, Powis J, Firestone Cruz M, Rudzinski K, Rehm J. Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol. 2008;20(1):29\u201332.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"875_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1478-3231.2008.01688.x","volume":"28","author":"J Mac\u00edas","year":"2008","unstructured":"Mac\u00edas J, Palacios RB, Claro E, Vargas J, Vergara S, Mira JA, et al. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack. Liver Int. 2008;28(6):781\u20136.","journal-title":"Liver Int"},{"issue":"6","key":"875_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0306-4603(96)00042-1","volume":"21","author":"GA Marlatt","year":"1996","unstructured":"Marlatt GA. Harm reduction: come as you are. Addict Behav. 1996;21(6):779\u201388.","journal-title":"Addict Behav"},{"issue":"1","key":"875_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12954-017-0178-6","volume":"14","author":"DC Des Jarlais","year":"2017","unstructured":"Des Jarlais DC. Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduct J. 2017;14(1):51.","journal-title":"Harm Reduct J"},{"issue":"6","key":"875_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMc2015435","volume":"383","author":"AH Kral","year":"2020","unstructured":"Kral AH, Lambdin BH, Wenger LD, Davidson PJ. Evaluation of an unsanctioned safe consumption site in the United States. N Engl J Med. 2020;383(6):589\u201390.","journal-title":"N Engl J Med"},{"issue":"2","key":"875_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/QAI.0000000000002849","volume":"89","author":"LW Suen","year":"2022","unstructured":"Suen LW, Davidson PJ, Browne EN, Lambdin BH, Wenger LD, Kral AH. Effect of an unsanctioned safe consumption site in the United States on syringe sharing, rushed injections, and isolated injection drug use: a longitudinal cohort analysis. JAIDS J Acquir Immune Defic Syndr. 2022;89(2):172\u20137.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"875_CR10","unstructured":"Harm reduction center pilot program to combat overdose deaths becomes law [press release]. 2021."},{"key":"875_CR11","unstructured":"OnPoint. OnPoint NYC 2021 [Available from: https:\/\/onpointnyc.org\/."},{"issue":"6","key":"875_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3109\/14659891.2015.1112847","volume":"21","author":"IN Onyeka","year":"2016","unstructured":"Onyeka IN, Basnet S, Beynon CM, Tiihonen J, F\u00f6hr J, Kauhanen J. Association between routes of drug administration and all-cause mortality among drug users. J Subst Use. 2016;21(6):559\u201365.","journal-title":"J Subst Use"},{"key":"875_CR13","unstructured":"Grund J-P, Coffin P, Jauffret-Roustide M, Dijkstra M, Bruin D, Blanken P. The fast and furious\u2014cocaine, amphetamines and harm reduction. 2010. p. 205\u201354."},{"key":"875_CR14","first-page":"1","volume":"1000","author":"D Riley","year":"2000","unstructured":"Riley D, O\u2019Hare P. Harm reduction: history, definition, and practice. Harm Reduct Natl Int Perspect. 2000;1000:1\u201326.","journal-title":"Harm Reduct Natl Int Perspect"},{"key":"875_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102829","volume":"83","author":"M Harris","year":"2020","unstructured":"Harris M. An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom. Int J Drug Policy. 2020;83: 102829.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"875_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2105\/AJPH.2019.305515","volume":"110","author":"DC Des Jarlais","year":"2020","unstructured":"Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K. Expansion of syringe service programs in the United States, 2015\u20132018. Am J Public Health. 2020;110(4):517\u20139.","journal-title":"Am J Public Health"},{"issue":"5","key":"875_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.amepre.2021.04.017","volume":"61","author":"TW Levengood","year":"2021","unstructured":"Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, et al. Supervised injection facilities as harm reduction: a systematic review. Am J Prev Med. 2021;61(5):738\u201349.","journal-title":"Am J Prev Med"},{"key":"875_CR18","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Drug consumption rooms: an overview of provision and evidence. 2018."},{"key":"875_CR19","unstructured":"Hedrich D. European report on drug consumption rooms. European Monitoring Centre for Drugs and Drug Addiction; 2004."},{"key":"875_CR20","unstructured":"Powell M. Drug Consumption Rooms: Saving lives, making communities safer. Drug Policy Foundation; 2019."},{"key":"875_CR21","unstructured":"Cook C, Bridge J, Stimson GV. Harm reduction: evidence, impacts and challenges. 2010. In: EMCDDA Monographs [Internet]. European Monitoring Centre for Drugs and Drug Addiction. Available from: https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/555\/EMCDDA-monograph10-harm_reduction_final_205049.pdf."},{"key":"875_CR22","doi-asserted-by":"publisher","DOI":"10.1596\/1813-9450-4553","volume-title":"The historical foundations of the narcotic drug control regime","author":"J Buxton","year":"2008","unstructured":"Buxton J. The historical foundations of the narcotic drug control regime. Washington: World Bank; 2008."},{"key":"875_CR23","unstructured":"Joint United Nations Programme on HIV\/AIDS. Health, Rights and Drugs: Harm reduction, decriminalization and zero discrimination for people who use drugs. United Nations; 2019."},{"key":"875_CR24","unstructured":"Rigoni R, Breeksema JJ, Woods S. Speed limits. Harm Reduction for People who use Stimulants 2018."},{"issue":"5","key":"875_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1177\/019459989310900525","volume":"109","author":"AJ Reino","year":"1993","unstructured":"Reino AJ, Lawson W. Upper airway distress in crack-cocaine users. Otolaryngol Head Neck Surg. 1993;109(5):937\u201340.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"875_CR26","unstructured":"Centers for Disease Control. Other Drugs 2021 [Available from: https:\/\/www.cdc.gov\/drugoverdose\/deaths\/other-drugs.html#:~:text=Rates%20of%20overdose%20deaths%20from,deaths%20in%202019%20involved%20psychostimulants."},{"issue":"3","key":"875_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF03403687","volume":"96","author":"E Haydon","year":"2005","unstructured":"Haydon E, Fischer B. Crack use as a public health problem in Canada: call for an evaluation of \u201csafer crack use kits.\u201d Can J Public Health. 2005;96(3):185\u20138.","journal-title":"Can J Public Health"},{"key":"875_CR28","unstructured":"United Nations Office on Drugs and Crime. HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs. Technical Guide. 2019."},{"issue":"12 Suppl 3","key":"875_CR29","first-page":"S486","volume":"7","author":"PD McElroy","year":"2003","unstructured":"McElroy PD, Rothenberg RB, Varghese R, Woodruff R, Minns GO, Muth SQ, et al. A network-informed approach to investigating a tuberculosis outbreak: implications for enhancing contact investigations. Int J Tuberc Lung Dis. 2003;7(12 Suppl 3):S486\u201393.","journal-title":"Int J Tuberc Lung Dis"},{"key":"875_CR30","unstructured":"Fact Sheet: The safer crack use program. In: Transnational Institute, editor. 2010."},{"issue":"1","key":"875_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12954-020-00414-y","volume":"17","author":"KA Speed","year":"2020","unstructured":"Speed KA, Gehring ND, Launier K, O\u2019Brien D, Campbell S, Hyshka E. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities. Harm Reduct J. 2020;17(1):72.","journal-title":"Harm Reduct J"},{"key":"875_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-016-0052-7","volume":"11","author":"C Strike","year":"2016","unstructured":"Strike C, Rotondi N, Watson T, Kolla G, Bayoumi A. Public opinions about supervised smoking facilities for crack cocaine and other stimulants. Subst Abuse Treat Prev Policy. 2016;11:1\u201310.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"875_CR33","unstructured":"Singh S, Banta-Green C, Kingston S. Distribution of Safer Drug Smoking Supplies as a Public Health Strategy: Addictions, Drug & Alcohol Institute; 2022 [Available from: https:\/\/adai.uw.edu\/Safer-Smoking-Brief-2022."},{"issue":"7","key":"875_CR34","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1086\/512081","volume":"195","author":"A Neaigus","year":"2007","unstructured":"Neaigus A, Gyarmathy VA, Zhao M, Miller M, Friedman SR, Des Jarlais DC. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. J Infect Dis. 2007;195(7):1052\u201361.","journal-title":"J Infect Dis"},{"issue":"1","key":"875_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-3-1","volume":"3","author":"K Shannon","year":"2006","unstructured":"Shannon K, Ishida T, Morgan R, Bear A, Oleson M, Kerr T, et al. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduct J. 2006;3(1):1.","journal-title":"Harm Reduct J"},{"key":"875_CR36","unstructured":"Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme2006."},{"issue":"1","key":"875_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-8-45","volume":"8","author":"J Thomas","year":"2008","unstructured":"Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(1):45.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"875_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13011-021-00414-6","volume":"16","author":"S Parent","year":"2021","unstructured":"Parent S, Papamihali K, Graham B, Buxton JA. Examining prevalence and correlates of smoking opioids in British Columbia: opioids are more often smoked than injected. Subst Abuse Treat Prev Policy. 2021;16(1):79.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"875_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12954-021-00479-3","volume":"18","author":"G Bardwell","year":"2021","unstructured":"Bardwell G, Austin T, Maher L, Boyd J. Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs. Harm Reduct J. 2021;18(1):29.","journal-title":"Harm Reduct J"},{"key":"875_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/851840","volume":"2013","author":"S Persaud","year":"2013","unstructured":"Persaud S, Tzemis D, Kuo M, Bungay V, Buxton JA. Controlling chaos: the perceptions of long-term crack cocaine users in Vancouver, British Columbia, Canada. J Addict. 2013;2013: 851840.","journal-title":"J Addict"},{"key":"875_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugpo.2017.05.059","volume":"48","author":"H Poliquin","year":"2017","unstructured":"Poliquin H, Bertrand K, Flores-Aranda J, Roy \u00c9. Understanding experiences of and rationales for sharing crack-smoking equipment: a qualitative study with persons who smoke crack in Montr\u00e9al. Int J Drug Policy. 2017;48:18\u201326.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"875_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1477-7517-5-24","volume":"5","author":"R Pizzey","year":"2008","unstructured":"Pizzey R, Hunt N. Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: an evaluation. Harm Reduct J. 2008;5(1):24.","journal-title":"Harm Reduct J"},{"issue":"1","key":"875_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-7517-11-18","volume":"11","author":"HJ St\u00f6ver","year":"2014","unstructured":"St\u00f6ver HJ, Sch\u00e4ffer D. SMOKE IT! Promoting a change of opiate consumption pattern\u2014from injecting to inhaling. Harm Reduct J. 2014;11(1):18.","journal-title":"Harm Reduct J"},{"issue":"7","key":"875_CR44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.drugpo.2015.01.015","volume":"26","author":"R McNeil","year":"2015","unstructured":"McNeil R, Kerr T, Lampkin H, Small W. \u201cWe need somewhere to smoke crack\u201d: an ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada. Int J Drug Policy. 2015;26(7):645\u201352.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"875_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1477-7517-5-34","volume":"5","author":"S Boyd","year":"2008","unstructured":"Boyd S, Johnson JL, Moffat B. Opportunities to learn and barriers to change: crack cocaine use in the Downtown Eastside of Vancouver. Harm Reduct J. 2008;5(1):34.","journal-title":"Harm Reduct J"},{"issue":"4","key":"875_CR46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.drugpo.2009.12.008","volume":"21","author":"V Bungay","year":"2010","unstructured":"Bungay V, Johnson JL, Varcoe C, Boyd S. Women\u2019s health and use of crack cocaine in context: structural and \u201ceveryday\u201d violence. Int J Drug Policy. 2010;21(4):321\u20139.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"875_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/dar.12180","volume":"34","author":"T Cheng","year":"2015","unstructured":"Cheng T, Wood E, Nguyen P, Montaner J, Kerr T, DeBeck K. Crack pipe sharing among street-involved youth in a Canadian setting. Drug Alcohol Rev. 2015;34(3):259\u201366.","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"875_CR48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/jurban\/jti051","volume":"82","author":"CL Collins","year":"2005","unstructured":"Collins CL, Kerr T, Kuyper LM, Li K, Tyndall MW, Marsh DC, et al. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use. J Urban Health. 2005;82(2):276\u201384.","journal-title":"J Urban Health"},{"issue":"1","key":"875_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12954-021-00482-8","volume":"18","author":"S Elkhalifa","year":"2021","unstructured":"Elkhalifa S, Jozaghi E, Marsh S, Thomson E, Gregg D, Buxton J, et al. Combining respondent-driven sampling with a community-based participatory action study of people who smoke drugs in two cities in British Columbia, Canada. Harm Reduct J. 2021;18(1):37.","journal-title":"Harm Reduct J"},{"issue":"4","key":"875_CR50","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/10826084.2018.1528460","volume":"54","author":"J Frankeberger","year":"2019","unstructured":"Frankeberger J, Cepeda A, Natera-Rey G, Valdez A. Safer crack kits and smoking practices: effectiveness of a harm reduction intervention among active crack users in Mexico City. Subst Use Misuse. 2019;54(4):592\u2013600.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"875_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/1049732312469465","volume":"23","author":"IE Handlovsky","year":"2013","unstructured":"Handlovsky IE, Bungay V, Johnson J, Phillips JC. The process of safer crack use among women in Vancouver\u2019s Downtown Eastside. Qual Health Res. 2013;23(4):450\u201362.","journal-title":"Qual Health Res"},{"issue":"1","key":"875_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-7517-9-9","volume":"9","author":"C Hunter","year":"2012","unstructured":"Hunter C, Strike C, Barnaby L, Busch A, Marshall C, Shepherd S, et al. Reducing widespread pipe sharing and risky sex among crystal methamphetamine smokers in Toronto: do safer smoking kits have a potential role to play? Harm Reduct J. 2012;9(1):9.","journal-title":"Harm Reduct J"},{"issue":"4","key":"875_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/009145091304000403","volume":"40","author":"A Ivsins","year":"2013","unstructured":"Ivsins A, Roth E, Benoit C, Fischer B. Crack pipe sharing in context: how sociostructural factors shape risk practices among noninjection drug users. Contemp Drug Probl. 2013;40(4):481\u2013503.","journal-title":"Contemp Drug Probl"},{"issue":"1","key":"875_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12954-016-0108-z","volume":"13","author":"E Jozaghi","year":"2016","unstructured":"Jozaghi E, Lampkin H, Andresen MA. Peer-engagement and its role in reducing the risky behavior among crack and methamphetamine smokers of the Downtown Eastside community of Vancouver, Canada. Harm Reduct J. 2016;13(1):19.","journal-title":"Harm Reduct J"},{"issue":"1","key":"875_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10826084.2020.1823416","volume":"56","author":"LE Leonard","year":"2021","unstructured":"Leonard LE, Wilson L, Germain A, Pelude L, Vannice S. The urgent need to respond to HIV- and HCV-related risk practices among Youth in Ottawa who smoke crack. Subst Use Misuse. 2021;56(1):1\u201310.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"875_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.drugpo.2007.02.008","volume":"19","author":"L Leonard","year":"2008","unstructured":"Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J. \u201cI inject less as I have easier access to pipes\u201d: injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. Int J Drug Policy. 2008;19(3):255\u201364.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"875_CR57","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.drugpo.2007.06.005","volume":"19","author":"L Malchy","year":"2008","unstructured":"Malchy L, Bungay V, Johnson J. Documenting practices and perceptions of \u201csafer\u201d crack use: a Canadian pilot study. Int J Drug Policy. 2008;19(4):339\u201341.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"875_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12954-019-0341-3","volume":"16","author":"R Rigoni","year":"2019","unstructured":"Rigoni R, Woods S, Breeksema JJ. From opiates to methamphetamine: building new harm reduction responses in Jakarta, Indonesia. Harm Reduct J. 2019;16(1):67.","journal-title":"Harm Reduct J"},{"issue":"1","key":"875_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12954-017-0144-3","volume":"14","author":"C Strike","year":"2017","unstructured":"Strike C, Watson TM. Education and equipment for people who smoke crack cocaine in Canada: progress and limits. Harm Reduct J. 2017;14(1):17.","journal-title":"Harm Reduct J"},{"issue":"1","key":"875_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1747-597X-6-34","volume":"6","author":"L Ti","year":"2011","unstructured":"Ti L, Buxton J, Wood E, Zhang R, Montaner J, Kerr T. Difficulty accessing crack pipes and crack pipe sharing among people who use drugs in Vancouver, Canada. Subst Abuse Treat Prev Policy. 2011;6(1):34.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"7","key":"875_CR61","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/j.1465-3362.2012.00446.x","volume":"31","author":"L Ti","year":"2012","unstructured":"Ti L, Buxton J, Wood E, Shannon K, Zhang R, Montaner J, et al. Factors associated with difficulty accessing crack cocaine pipes in a Canadian setting. Drug Alcohol Rev. 2012;31(7):890\u20136.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"875_CR62","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12889-016-3137-3","volume":"16","author":"P Voon","year":"2016","unstructured":"Voon P, Ti L, Dong H, Milloy MJ, Wood E, Kerr T, et al. Risky and rushed public crack cocaine smoking: the potential for supervised inhalation facilities. BMC Public Health. 2016;16(1):476.","journal-title":"BMC Public Health"},{"issue":"5","key":"875_CR63","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/10826084.2012.644170","volume":"47","author":"A Domanico","year":"2012","unstructured":"Domanico A, Malta M. Implementation of harm reduction toward crack users in Brazil: barriers and achievements. Subst Use Misuse. 2012;47(5):535\u201346.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"875_CR64","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.drugpo.2011.05.005","volume":"22","author":"A Ivsins","year":"2011","unstructured":"Ivsins A, Roth E, Nakamura N, Krajden M, Fischer B. Uptake, benefits of and barriers to safer crack use kit (SCUK) distribution programmes in Victoria, Canada\u2014a qualitative exploration. Int J Drug Policy. 2011;22(4):292\u2013300.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"875_CR65","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/BF03404893","volume":"102","author":"LA Malchy","year":"2011","unstructured":"Malchy LA, Bungay V, Johnson JL, Buxton J. Do crack smoking practices change with the introduction of safer crack kits? Can J Public Health. 2011;102(3):188\u201392.","journal-title":"Can J Public Health"},{"issue":"5","key":"875_CR66","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/dar.12815","volume":"37","author":"S Cortina","year":"2018","unstructured":"Cortina S, Kennedy MC, Dong H, Fairbairn N, Hayashi K, Milloy MJ, et al. Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada. Drug Alcohol Rev. 2018;37(5):645\u201352.","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"875_CR67","doi-asserted-by":"publisher","first-page":"210","DOI":"10.17269\/s41997-019-00180-w","volume":"110","author":"S Bourque","year":"2019","unstructured":"Bourque S, Pijl EM, Mason E, Manning J, Motz T. Supervised inhalation is an important part of supervised consumption services. Can J Public Health. 2019;110(2):210\u20135.","journal-title":"Can J Public Health"},{"issue":"1","key":"875_CR68","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12889-017-4099-9","volume":"17","author":"A Prangnell","year":"2017","unstructured":"Prangnell A, Dong H, Daly P, Milloy MJ, Kerr T, Hayashi K. Declining rates of health problems associated with crack smoking during the expansion of crack pipe distribution in Vancouver, Canada. BMC Public Health. 2017;17(1):163.","journal-title":"BMC Public Health"},{"key":"875_CR69","unstructured":"Interior Health. Harm reduction supplies\u2014safer smoking supplies. In: Health I, editor."},{"key":"875_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100163","volume":"7","author":"MC Reid","year":"2023","unstructured":"Reid MC, Oliphant-Wells T, Moreno C, Ketchum J, Fitzpatrick T, McMahan VM, et al. High levels of interest in access to free safer smoking equipment to reduce injection frequency among people who inject drugs in Seattle, Washington. Drug Alcohol Depend Rep. 2023;7: 100163.","journal-title":"Drug Alcohol Depend Rep"},{"key":"875_CR71","unstructured":"Davis C. Laws that Criminalize Paraphernalia Increase Drug-Related Harm and Should Be Repealed2022; 2022. Available from: https:\/\/www.networkforphl.org\/news-insights\/laws-that-criminalize-paraphernalia-increase-drug-related-harm-and-should-be-repealed\/."},{"key":"875_CR72","unstructured":"Giliauskas D. A review of supervised inhalation services in Canada. Ontario HIV Treatment Network; 2022."},{"key":"875_CR73","unstructured":"Policy Surveillance Program Staff. Syringe Services Programs Laws: Prescription Drug Abuse Policy System; 2021 [Available from: https:\/\/pdaps.org\/datasets\/syringe-services-programs-laws."},{"key":"875_CR74","unstructured":"Subramaniam T. Fact Check: Biden admin isn\u2019t funding crack pipes: CNN; 2022 [Available from: https:\/\/www.cnn.com\/2022\/02\/17\/politics\/federal-funds-crack-pipe-fact-check\/index.html."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00875-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00875-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00875-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T21:03:26Z","timestamp":1698440606000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00875-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00875-x","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author\u2019s AT, CA, ZGL, and NN were paid researchers on behalf of Smokeworks Injection Alternatives. Smokeworks had no control over design and interpretation of results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}